Bacterial Colitis

ABSTRACT

Bacterial colitis results in an inflammatory-type diarrhea that is characterized by bloody, purulent, and mucoid stool. These diseases have been designated as bacterial hemorrhagic enterocolitis. Associated symptoms include fever, tenesmus, and severe abdominal pain. The pathologic changes range from superficial exudative enterocolitis to a transmural enterocolitis with ulceration. Common pathologic bacteria causing bacterial colitis include Campylobacter, Salmonella, Shigella, Escherichia, and Yersinia species. The primary source of transmission is fecal-oral spread and ingestion of contaminated food and water. Although detailed history and identification of specific risk factors assist in the diagnosis, definitive diagnosis requires bacterial identification. Therefore, the physician must be familiar with the disease pathophysiology, epidemiology, and specific diagnostic modalities for clinical diagnosis and management. Specific tests are used to detect enteric pathogens and include stool and rectal swab culture, histology, and identification of specific bacterial toxins. Although many of these bacterial colitis infections are self-limiting, antibiotics should be used for high-risk patients and patients with complicated disease.

Bacteria - colitis - diarrhea - dysentery

REFERENCES

• 1 Ilnyckyj A. Clinical evaluation and management of acute infectious diarrhea in adults.  Gastroenterol Clin North Am. 2001;  30 599-609
• 2 Ryan C A, Nickels M, Hargrett-Bean N T et al.. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk.  JAMA. 1987;  258 3269-3274
• 3 MacKenzie W R, Schell W L, Blair K A et al.. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission.  Clin Infect Dis. 1995;  21 57-62
• 4 Ina K, Kusugami K, Ohta M. Bacterial hemorrhagic enterocolitis.  J Gastroenterol. 2003;  38 111-120
• 5 Macdonald K L, O'Leary M J, Cohen M L et al.. Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study.  JAMA. 1988;  259 3567-3570
• 6 Peterson M C. Clinical aspects of Campylobacter jejuni infections in adults.  West J Med. 1994;  161 148-152
• 7 Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity.  J Med Microbiol. 2000;  49 305-311
• 8 Altekruse S F, Stern N J, Fields P I, Swerdlow D L. Campylobacter jejuni-an emerging foodborne pathogen.  Emerg Infect Dis. 1999;  5 28-35
• 9 Jacobs B C, van Doorn P A, Schmitz P I et al.. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.  Ann Neurol. 1996;  40 181-187
• 10 Loss R W, Mangla J C, Pereira M. Campylobacter colitis presenting as inflammatory bowel disease with segmental colonic ulcerations.  Gastroenterology. 1980;  79 138-140
• 11 Matsumoto T, Iida M, Kimura Y, Fujishima M. Culture of colonoscopically obtained biopsy specimens in acute infectious colitis.  Gastrointest Endosc. 1994;  40 184-187
• 12 Oldfield E C, Wallace M R. The role of antibiotics in the treatment of infectious diarrhea.  Gastroenterol Clin North Am. 2001;  30 817-836
• 13 Smith K E, Besser J M, Hedberg C W et al.. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998.  N Engl J Med. 1999;  340 1525-1532
• 14 Levine M M. Antimicrobial therapy for infectious diarrhea.  Rev Infect Dis. 1986;  8 S207-S216
• 15 Hoffner R J, Slaven E, Perez J, Magana R N, Henderson S O. Emergency department presentations of typhoid fever.  J Emerg Med. 2000;  19 317-321
• 16 Hohmann E L. Nontyphoidal salmonellosis.  Clin Infect Dis. 2001;  32 263-269
• 17 Chaudhuri A, Bekdash B A. Toxic megacolon due to Salmonella: a case report and review of the literature.  Int J Colorectal Dis. 2002;  17 275-279
• 18 Musher D M, Rubenstein A D. Permanent carriers of nontyphosa salmonellae.  Arch Intern Med. 1973;  132 869-872
• 19 Cariani G, Vandelli A. Salmonellosis-induced hemorrhage and ulcerations of the colon.  Endoscopy. 1993;  25 488
• 20 Dagash M, Hayek T, Guallimidi Z, Yassin K, Brook J G. Transient radiological and colonoscopic features of inflammatory bowel disease in a patient with severe Salmonella gastroenteritis.  Am J Gastroenterol. 1997;  92 349-351
• 21 Kamath R. Antibiotic therapy for Salmonella enteritis.  J Paediatr Child Health. 1999;  35 372-374
• 22 Sanchez C, Garcia-Restoy E, Garau J et al.. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.  J Infect Dis. 1993;  168 1304-1307
• 23 Rodriguez-Noriega E, Andrade-Villanueva J, Amaya-Tapia G. Quinolones in the treatment of Salmonella carriers.  Rev Infect Dis. 1989;  11 S1179-S1187
• 24 Kotloff K L, Winickott J P, Ivanoff B et al.. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.  Bull World Health Organ. 1999;  77 651-666
• 25 DuPont H L, Hornick R B, Snyder M J, Libonati J P, Formal S B, Gangarosa E J. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.  J Infect Dis. 1972;  125 12-16
• 26 Mohle-Boetani J C, Stapleton M, Finger R et al.. Community wide shigellosis: control of an outbreak and risk factors in child day-care centers.  Am J Public Health. 1995;  85 812-816
• 27 O'Sullivan B, Delpech V, Pontivivo G et al.. Shigellosis linked to sex venues, Australia.  Emerg Infect Dis. 2002;  8 862-864
• 28 Sandvig K. Shigatoxins.  Toxicon. 2001;  39 1629-1635
• 29 Bennish M L. Potentially lethal complications of shigellosis.  Rev Infect Dis. 1991;  13 S319-S324
• 30 Tsuchiya N, Husby G, Williams R C et al.. Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid.  J Clin Invest. 1990;  86 1193-1203
• 31 Speelman P, Kabir I, Islam M. Distribution and spread of colonic lesions in Shigellosis: a colonoscopic study.  J Infect Dis. 1984;  150 899-903
• 32 Khuroo M S, Mahajan R, Zargar S A et al.. The colon in Shigellosis: serial colonoscopic appearances in Shigella dysenteriae. I.  Endoscopy. 1990;  22 35-38
• 33 Lawson J M. Update on Escherichia coli O157:H7.  Curr Gastroenterol Rep. 2004;  6 297-301
• 34 Tarr P I, Neill M A. Escherichia coli O157:H7.  Gastroenterol Clin North Am. 2001;  30 735-751
• 35 Griffin P, Mead P, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagic E. coli . In: Blaser M, Smith P, Greenberg H, et al Infections of the Gastrointestinal Tract. Philadelphia; Lippincott Williams & Wilkins 2002: 627-642
• 36 Huang D, Okhuysen P, Jiang Z et al.. Enteroaggregative Escherichia coli: an emerging enteric pathogen.  Am J Gastroenterol. 2004;  99 383-389
• 37 Moake J L. Thrombotic microangiopathies.  N Engl J Med. 2002;  347 589-600
• 38 Crump J A, Sulka A C, Langer A J et al.. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm.  N Engl J Med. 2002;  347 555-560
• 39 Shigeno T, Akamatsu T, Fujimori K, Nakatsuji Y, Nagata A. The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection.  Endoscopy. 2002;  34 311-314
• 40 Kelly J, Oryshak A, Wenetsek M, Grabiec J, Handy S. The colonic pathology of Escherichia coli O157:H7 infection.  Am J Surg Pathol. 1990;  14 87-92
• 41 Miller F H, Ma J J, Scholz F J. Imaging features of enterohemorrhagic Escherichia coli colitis.  AJR Am J Roentgenol. 2001;  177 619-623
• 42 Proulx F, Turgeon J, Delage G et al.. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.  J Pediatr. 1992;  121 299-303
• 43 Carter A O, Borczyk A, Carlson J et al.. A severe outbreak of Escherichia coli O157:H7 associated hemorrhagic colitis in a nursing home.  N Engl J Med. 1987;  317 1496-1500
• 44 Ostroff S M, Kobayashi J M, Lewis J H. Infections of Escherichia coli O157:H7 in Washington State, the first year of statewide disease surveillance.  JAMA. 1989;  262 355-359
• 45 Ryan C A, Tauxe R, Hosek G et al.. Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings.  J Infect Dis. 1986;  154 631-638
• 46 Karch H, Strockbine N A, O'Brien A D. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of shiga-like toxin producing strains by colony blot assay.  FEMS Microbiol Lett. 1986;  35 141-145
• 47 Zhang X, McDaniel A, Wolf L et al.. Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice.  J Infect Dis. 2000;  181 664-670
• 48 Cimolai N, Carter J, Morrison B et al.. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.  J Pediatr. 1990;  116 589-592
• 49 Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases.  Int J Dermatol. 1998;  37 667-672
• 50 Kato Y, Hattori Y, Ohya H, Yoshino S, Kato H. Acute terminal ileitis and Yersinia enterocolitica infection.  Gastroenterol Jpn. 1977;  12 36-43
• 51 Matsumoto T, Iida M, Matsui T et al.. Endoscopic findings in Yersinia enterocolitica enterocolitis.  Gastrointest Endosc. 1990;  36 583-587
• 52 Tuohy A M, O'Gorman M, Byington C, Reid B, Jackson W D. Yersinia enterocolitis mimicking disease in a toddler.  Pediatrics. 1999;  104 36
• 53 Pham J, Bell S, Lanzarone J. Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica. .  J Antimicrob Chemother. 1991;  28 13-18
• 54 Preston M A, Brown S, Borczyk A et al.. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated from Canada from 1972 to 1990.  Antimicrob Agents Chemother. 1994;  38 2121-2124
• 55 Scavizzi M R, Alonso J, Philippon A, Jupeau-Vessieres A M, Guiyoule A. Failure of newer β-lactam antibiotics for murine Yersinia enterocolitica infection.  Antimicrob Agents Chemother. 1987;  31 523-526
• 56 Han J K, Kim S H, Choi B I, Yeon K M, Han M C. Tuberculous colitis: findings at double-contrast barium enema examination.  Dis Colon Rectum. 1996;  39 1204-1209
• 57 Horvath K D, Whelan R L, Weinstein S, Basner A L, Staugaitis S M, Greenebaum E. Isolated sigmoid tuberculosis. Report of a case.  Dis Colon Rectum. 1995;  38 1327-1330
• 58 Breiter J R, Hajjar J J. Segmental tuberculosis of the colon diagnosed by colonoscopy.  Am J Gastroenterol. 1981;  76 369-373
• 59 Anand B. Abdominal tuberculosis. In: Weinstein WM, Hawkey CJ, Bosch J Clinical Gastroenterology and Hepatology. Philadelphia; Elsevier Mosby 2005: 331-336
• 60 Guth A A, Kim U. The reappearance of abdominal tuberculosis.  Surg Gynecol Obstet. 1991;  172 432-436
• 61 Lisehora G B, Peters C C, Lee Y T, Barcia P J. Tuberculous peritonitis-do not miss it.  Dis Colon Rectum. 1996;  39 394-399
• 62 Quinn T C, Goodell S E, Mkrtichian E, Schuffler M D, Wang S P, Stamm W E. Chlamydia trachomatis proctitis.  N Engl J Med. 1981;  305 195-200
• 63 Tinmouth J, Rachlis A, Wesson T, Hsieh E. Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists.  Clin Gastroenterol Hepatol. 2006;  4 469-473
• 64 Rompalo A M. Diagnosis and treatment of sexually acquired proctitis and proctocolitis: an update.  Clin Infect Dis. 1999;  28 S84-S90
• 65 Catterall R D. Sexually transmitted disease of the anus and rectum.  Clin Gastroenterol. 1975;  4 659-669
• 66 Corman M L. Colon and rectal surgery. 5th ed. Philadelphia; Lippincott Williams & Wilkins 2005: 1648-1650
• 67 Schwebke J R, Whittington W, Rice R J, Handsfield H H, Hale J, Holmes K K. Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985-1991.  Antimicrob Agents Chemother. 1995;  39 917-920